Category: Latest News

  • Gold pulls back, ending four-session rally

    Gold pulls back, ending four-session rally

    Gold prices moved lower on Tuesday after reaching a three-week peak, snapping a four-day run of gains as investors locked in profits and the U.S. dollar strengthened amid renewed uncertainty surrounding American trade tariffs. At 04:30 ET (09:30 GMT), spot gold fell 1.1% to $5,170.51 per ounce, retreating after earlier touching its highest level since…

  • Bitcoin falls below $63k, down 50% from October peak amid tariff uncertainty

    Bitcoin falls below $63k, down 50% from October peak amid tariff uncertainty

    Bitcoin (COIN:BTCUSD) declined on Tuesday, extending its recent slide and now trading roughly 50% below its record high reached in October, as uncertainty surrounding U.S. trade policy dampened investor appetite for risk assets including cryptocurrencies. The broader crypto market also remained under pressure, with both institutional and retail investors continuing to reduce exposure. Rising geopolitical…

  • AI disruption concerns and new Trump tariffs dominate market focus; key earnings ahead: Dow Jones, S&P, Nasdaq, Wall Street Futures

    AI disruption concerns and new Trump tariffs dominate market focus; key earnings ahead: Dow Jones, S&P, Nasdaq, Wall Street Futures

    U.S. equity futures traded cautiously on Tuesday as investors weighed concerns over artificial intelligence–driven disruption while preparing for a busy week of corporate earnings. Sentiment was also shaped by the implementation of President Donald Trump’s new 10% global tariffs following a Supreme Court ruling that invalidated earlier emergency trade measures. Meanwhile, Paramount Skydance (NASDAQ:PSKY) has…

  • Three hot stocks for the upcoming uranium boom: Cameco, Stallion Uranium, and Uranium Energy

    Three hot stocks for the upcoming uranium boom: Cameco, Stallion Uranium, and Uranium Energy

    The global hunger for energy is growing – and uranium is back in the spotlight. Artificial intelligence, data centers, and mounting climate pressure are driving a renewed commitment to nuclear power worldwide. Investors looking to benefit from this trend are increasingly turning to uranium-focused companies. Three names stand out: Cameco, the Canadian market leader; Uranium…

  • Renewed Tariff Uncertainty Contributes To Sell-Off On Wall Street

    Renewed Tariff Uncertainty Contributes To Sell-Off On Wall Street

    After turning in a strong performance last week, stocks moved sharply lower during trading on Monday. The major averages all showed significant moves to the downside, with the Dow tumbling to its lowest closing level in a month. The major averages ended the day off their lows of the session but still firmly negative. The…

  • Warner Bros. Discovery shares gain after report of higher takeover bid

    Warner Bros. Discovery shares gain after report of higher takeover bid

    Warner Bros. Discovery (NASDAQ:WBD) shares edged 1.5% higher on Monday after a media report indicated that Paramount is preparing to submit a revised acquisition proposal valuing the company at $32 per share. According to Variety, sources familiar with the matter said Paramount Skydance, led by David Ellison, is expected to increase its offer from a…

  • Shutterstock shares rise after DOJ approves Getty Images merger

    Shutterstock shares rise after DOJ approves Getty Images merger

    Shutterstock (NYSE:SSTK) shares climbed about 5% on Monday, while Getty Images (NYSE:GETY) gained 7%, after the U.S. Department of Justice granted antitrust clearance for the companies’ proposed merger of equals. The DOJ completed its review and allowed the waiting period under the Hart-Scott-Rodino Act to expire without imposing conditions, the companies said, marking a key…

  • Eli Lilly shares gain after Novo Nordisk obesity drug falls short in trial

    Eli Lilly shares gain after Novo Nordisk obesity drug falls short in trial

    Shares of Eli Lilly (NYSE:LLY) rose 2.8% to $1,037 in premarket trading Monday after rival Novo Nordisk (CSE:NOVOb) reported that its experimental obesity treatment CagriSema failed to meet a key clinical trial objective. Novo Nordisk said the study did not demonstrate that CagriSema was non-inferior to Eli Lilly’s Tirzepatide in reducing body weight. Trial data…

  • Allurion shares soar after FDA clears Smart Capsule weight-loss device

    Allurion shares soar after FDA clears Smart Capsule weight-loss device

    Allurion Technologies (NYSE:ALUR) shares jumped about 40% after the company announced it had received U.S. Food and Drug Administration approval for its Allurion Gastric Balloon System, which includes the Allurion Smart Capsule. The FDA granted premarket approval for the weight-loss treatment, opening access to an estimated 80 million Americans with obesity who fall within the…

  • FTC Solar Stock Gains After Signing Three-Year Supply Agreement in South Africa

    FTC Solar Stock Gains After Signing Three-Year Supply Agreement in South Africa

    FTC Solar Inc. (NASDAQ:FTCI) shares rose 4.9% to $8.59 in premarket trading Monday after the company revealed a new three-year supply partnership with South African solar procurement firm Lubanzi Inala. Under the deal, FTC Solar will provide roughly 840 megawatts of solar tracking systems to Lubanzi over the duration of the agreement, with the first…